Aktis Oncology, Inc.
(AKTS - NASDAQ)
20,09 USD
📋 Profilo Aziendale

Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment.

|